These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17202998)
1. The pitfalls in the development of biologic therapy. Maini RN; Feldmann M Nat Clin Pract Rheumatol; 2007 Jan; 3(1):1. PubMed ID: 17202998 [No Abstract] [Full Text] [Related]
2. International guidelines on access to biologic therapy: why the differences and which is best? Deighton C; Hyrich K Nat Clin Pract Rheumatol; 2008 Oct; 4(10):520-1. PubMed ID: 18665149 [No Abstract] [Full Text] [Related]
3. Abatacept: new drug. Rheumatoid arthritis: after failure of TNF alpha antagonists and rituximab. Prescrire Int; 2008 Dec; 17(98):232. PubMed ID: 19422143 [No Abstract] [Full Text] [Related]
4. Small molecule challenges dominance of TNF-alpha inhibitors. Sheridan C Nat Biotechnol; 2008 Feb; 26(2):143-4. PubMed ID: 18259158 [No Abstract] [Full Text] [Related]
5. Economics of biological therapies. Kelly CJ; Mir FA BMJ; 2009 Aug; 339():b3276. PubMed ID: 19700510 [No Abstract] [Full Text] [Related]
6. Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis. Franklin G; Greenspan J; Chen S Ann Clin Lab Sci; 2009; 39(2):192-5. PubMed ID: 19429808 [TBL] [Abstract][Full Text] [Related]
7. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis. Geraghty EM; Ristow B; Gordon SM; Aronowitz P Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458 [TBL] [Abstract][Full Text] [Related]
10. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials. Gerlag DM; Tak PP Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687 [TBL] [Abstract][Full Text] [Related]
11. Comparative overview of safety of the biologics in rheumatoid arthritis. Khraishi M J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327 [TBL] [Abstract][Full Text] [Related]
12. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents. Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227 [No Abstract] [Full Text] [Related]